{"result": "{\n    \"title\": \"Breast Cancer Treatment Community\",\n    \"summary\": \"The community revolves around breast cancer treatment, with entities such as pembrolizumab, AC regime, and PCR rate playing crucial roles. Pembrolizumab is an immunotherapy drug used in the treatment of breast cancer, while AC regime is a chemotherapy regimen used in combination with pembrolizumab. PCR rate is a concept that measures the effectiveness of treatment.\",\n    \"rating\": 6.5,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for improved treatment outcomes and the significance of the entities involved.\",\n    \"findings\": [\n        {\n            \"summary\": \"Pembrolizumab's role in breast cancer treatment\",\n            \"explanation\": \"Pembrolizumab is an immunotherapy drug used in the treatment of breast cancer, with a higher pathological complete response (pCR) rate in HR+/HER2- subtype breast cancer patients compared to the control arm [Data: Entities (259), Relationships (85, 287, 289)]. Pembrolizumab is being studied in combination with AC regime for its effect on pCR rate in breast cancer patients [Data: Relationships (287)].\"\n        },\n        {\n            \"summary\": \"AC regime's role in breast cancer treatment\",\n            \"explanation\": \"AC regime is a chemotherapy regimen used in combination with pembrolizumab for breast cancer treatment [Data: Relationships (145)]. AC regime and paclitaxel are used together in a chemotherapy regimen for breast cancer treatment [Data: Relationships (145)].\"\n        },\n        {\n            \"summary\": \"PCR rate's significance in breast cancer treatment\",\n            \"explanation\": \"PCR rate is a concept that measures the effectiveness of treatment, with pembrolizumab demonstrating a higher pCR rate compared to the control arm in breast cancer patients [Data: Relationships (250)]. PCR rate is used to assess the effectiveness of treatments for breast cancer and IBC, providing valuable information for healthcare professionals and researchers [Data: Entities (187)].\"\n        },\n        {\n            \"summary\": \"I-SPY2 trial's significance in breast cancer treatment\",\n            \"explanation\": \"The I-SPY2 trial is a clinical trial focused on breast cancer, evaluating the effect of pembrolizumab on the pCR rate in high-risk stage II-III breast cancer patients [Data: Relationships (286)].\"\n        },\n        {\n            \"summary\": \"Triple-negative subtype's significance in breast cancer treatment\",\n            \"explanation\": \"Pembrolizumab demonstrates a higher pCR rate in triple-negative subtype breast cancer patients compared to the control arm [Data: Relationships (288)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n259,\"\"\"PEMBROLIZUMAB\"\"\",\"Here is a comprehensive summary of the data:\n\nPembrolizumab is an immunotherapy drug used in the treatment of various types of cancer, including breast cancer and inflammatory breast cancer (IBC). It has been used in clinical trials and is a type of immunotherapy used in the treatment of IBC.\",6\r\n330,\"\"\"AC REGIME\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"AC REGIME\"\" is a chemotherapy regimen used in the treatment of breast cancer. It is a specific treatment protocol designed to combat breast cancer, with the goal of eradicating or controlling the disease.\",2\r\n187,\"\"\"PCR RATE\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"PCR Rate\"\" is a concept or marker that measures the effectiveness of treatment, specifically in the context of breast cancer and inflammatory breast cancer (IBC). It is an endpoint in clinical trials for IBC and refers to the percentage of patients who achieve a pathologic complete response (pCR) to treatment. In other words, the pCR rate is the rate of patients who achieve a complete response to treatment, as determined by a pathologic examination of the breast tissue. This rate is used to assess the effectiveness of treatments for breast cancer and IBC, providing valuable information for healthcare professionals and researchers.\",2\r\n332,\"\"\"HR+/HER2- SUBTYPE\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"HR+/HER2- SUBTYPE\"\" refers to a type of breast cancer that is characterized by the presence of estrogen receptors (HR+) and the absence of HER2 receptors (HER2-). This subtype of breast cancer is positive for estrogen receptor and negative for HER2.\",1\r\n329,\"\"\"I-SPY2 TRIAL\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"I-SPY2 TRIAL\"\" is a clinical trial focused on breast cancer. Specifically, it is a phase 2 clinical trial that aims to evaluate the effect of pembrolizumab on the pathologic complete response (pCR) rate in high-risk stage II-III breast cancer patients.\n\nNote: I resolved the minor contradictions in the descriptions by combining the information to provide a clear and concise summary.\",1\r\n331,\"\"\"TRIPLE-NEGATIVE SUBTYPE\"\"\",\"Here is a comprehensive summary of the data:\n\nThe \"\"TRIPLE-NEGATIVE SUBTYPE\"\" refers to a type of breast cancer that lacks specific receptors. Specifically, it is characterized by being negative for estrogen receptors, progesterone receptors, and HER2 receptors. This means that the cancer cells do not have these receptors on their surface, which are typically targeted by hormone therapy and HER2-targeted therapies.\n\nNote: I resolved the contradictions by combining the two descriptions, ensuring that the summary is accurate and coherent.\",1\r\n294,\"\"\"PLACEBO\"\"\",\"Here is a comprehensive summary of the data:\n\nPlacebo is a type of control treatment used in clinical trials. Specifically, it refers to a control group in a clinical trial.\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n85,\"\"\"IBC\"\"\",\"\"\"PEMBROLIZUMAB\"\"\",\"\"\"Pembrolizumab is used in the treatment of IBC, a type of breast cancer characterized by rapid onset and aggressive growth.\"\"\",60\r\n145,\"\"\"PACLITAXEL\"\"\",\"\"\"AC REGIME\"\"\",\"\"\"AC regime and paclitaxel are used together in a chemotherapy regimen for breast cancer treatment.\"\"\",10\r\n287,\"\"\"PEMBROLIZUMAB\"\"\",\"\"\"AC REGIME\"\"\",\"\"\"pembrolizumab is being studied in combination with AC regime for its effect on pCR rate in breast cancer patients.\"\"\",8\r\n250,\"\"\"PCR RATE\"\"\",\"\"\"PEMBROLIZUMAB\"\"\",\"Here is a comprehensive summary of the data:\n\nPembrolizumab is a medication being studied for its effect on the Pathological Complete Response (pCR) rate in breast cancer patients. Research has shown that pembrolizumab is associated with a higher pCR rate compared to the control arm in breast cancer treatment. This suggests that pembrolizumab may be an effective treatment option for breast cancer patients, potentially leading to improved outcomes.\",8\r\n289,\"\"\"PEMBROLIZUMAB\"\"\",\"\"\"HR+/HER2- SUBTYPE\"\"\",\"Here is a comprehensive summary of the data:\n\nPembrolizumab demonstrates a higher pathological complete response (pCR) rate in HR+/HER2- subtype breast cancer patients compared to the control arm. The treatment shows improved pCR rates in this specific subtype of breast cancer, indicating its potential as a effective therapy for HR+/HER2- breast cancer patients.\n\nNote: I resolved the contradictions by combining the two descriptions into a single sentence, ensuring that the summary is coherent and accurate.\",7\r\n286,\"\"\"PEMBROLIZUMAB\"\"\",\"\"\"I-SPY2 TRIAL\"\"\",\"\"\"pembrolizumab is being evaluated in the I-SPY2 trial for its effect on pCR rate in high-risk stage II-III breast cancer.\"\"\",7\r\n288,\"\"\"PEMBROLIZUMAB\"\"\",\"\"\"TRIPLE-NEGATIVE SUBTYPE\"\"\",\"Here is a comprehensive summary of the data:\n\nPembrolizumab demonstrates a higher pathological complete response (pCR) rate in triple-negative subtype breast cancer patients compared to the control arm. The treatment shows improved pCR rates in this patient population, indicating its potential as a effective therapy for triple-negative subtype breast cancer.\n\nNote: I resolved the contradictions by combining the two descriptions into a single sentence, ensuring that the summary is coherent and accurate.\",7\r\n251,\"\"\"PCR RATE\"\"\",\"\"\"PLACEBO\"\"\",\"\"\"placebo is used as a control group in clinical trials to compare the effect of pembrolizumab on pCR rate.\"\"\",3\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": null}}